US Stock MarketDetailed Quotes

HUMA Humacyte

Watchlist
  • 5.180
  • +0.130+2.57%
Close Jan 2 16:00 ET
  • 5.121
  • -0.059-1.14%
Post 20:01 ET
666.50MMarket Cap-3.87P/E (TTM)

About Humacyte Company

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Company Profile

SymbolHUMA
Company NameHumacyte
Listing DateDec 1, 2020
Founded2004
CEOMs. Laura E. Niklason
MarketNASDAQ
Employees185
Fiscal Year Ends12-31
Address2525 East North Carolina Highway 54
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-313-9633

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Laura E. Niklason
  • President, Chief Executive Officer and Director
  • 2.63M
  • Shamik J. Parikh
  • Chief Medical Officer
  • --
  • Dale A. Sander
  • Principal Accounting Officer, Chief Financial Officer, Chief Corporate Development Officer and Treasurer
  • 1.35M
  • Dr. Heather Prichard
  • Chief Operating Officer
  • 1.27M
  • William John Scheessele
  • Chief Commercial Officer
  • --
  • Dr. Yang Cao
  • Chief Regulatory Officer
  • --
  • Kathleen Sebelius
  • Chairman of the Board
  • 96.76K
  • Brady W. Dougan
  • Director
  • 71.76K
  • Rajiv Shukla
  • Director
  • 71.76K
  • Gordon M. Binder
  • Independent Director
  • 71.76K
  • Dr. Susan Richards Windham-Bannister, PhD
  • Independent Director
  • 71.76K
  • Dr. Keith Anthony Jones
  • Independent Director
  • --
  • Max Wallace
  • Independent Director
  • 76.76K
  • C. Bruce Green
  • Independent Director
  • 71.76K
  • Dr. Emery N. Brown
  • Independent Director
  • 71.76K
  • Dr. John P. Bamforth
  • Independent Director
  • --
  • Todd M. Pope
  • Independent Director
  • 76.76K
  • Michael T. Constantino
  • Independent Director
  • 79.26K
  • Diane Seimetz
  • Independent Director
  • 71.76K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.